Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Polyps Market Size

ID: MRFR//2832-HCR | 80 Pages | Author: Rahul Gotadki| April 2024

The POLYPS market is largely affected by polyp prevalence and incidence. Polyp prevalence increases need for diagnostic and therapeutic options, driving market growth.
Age is a major factor in polyp growth, with older people affected more. Market growth occurs when the global population ages and the target audience for polyp-related products and services grows.
Polyps occur due to lifestyle choices including smoking and eating and family history. Awareness and preventive measures are becoming increasingly vital to understand and manage to affect market dynamics.
Endoscopy and imaging innovations affect the POLYPS industry. Improved detection leads to early diagnosis, which increases intervention and treatment demand.
Continuous research and polyp treatment innovations are driving market growth. Market players may meet changing healthcare needs with new treatment options including less invasive procedures and tailored drug therapy.
Government efforts to raise awareness, prevent polyps, and diagnose them early are crucial. Screening programs and policies that reduce colorectal disease burdens might grow the market.
Polyp-related services are linked to healthcare infrastructure in different regions. Strong healthcare facilities generally increase diagnostic and treatment acceptance, which affects market size.
Patient awareness and education significantly impact market dynamics. Increased awareness of polyps, their risk factors, and the need of regular screenings may encourage early treatments, which will benefit the market.
Insurance coverage and healthcare spending affect polyp-related treatment demand. Increased diagnostic and treatment choices are due to good coverage and cost.
Market dynamics are affected by major companies and their strategies. Innovation, Strategic Partnerships, and Mergers and Acquisitions make the POLYPS sector competitive.
Regulatory frameworks and compliance standards govern polyp-related product development and marketing. These restrictions safeguard product quality and safety, affecting market entry and sustainability.
Global economic considerations may affect healthcare spending and medical research. Economic stability or volatility may affect POLYPS market growth.

Polyps Market Overview


The Polyps Market is anticipated to reach USD 2,273.4 Milion by 2030 at 11.3% CAGR during the forecast period 2022-2030.


A polyp is an abnormal growth of tissue projecting from a mucous membrane commonly found in the colon, stomach, nose, ear, sinus, urinary bladder, uterus etc. although they may occur elsewhere in the body where mucous membranes exist. Most polyps are benign or non-cancerous while a few are premalignant. Premalignant polyps can be a trigger factors for cancer and in general, the larger the polyp, the greater the risk of cancer, especially with pre-malignant polyps. Most polyps have no symptoms and screening is the only reliable measure to detect them. Symptoms, when evident, are irregular periods and vaginal bleeding in women, dysmenorrhea, pain, diarrhoea, constipation, nausea, vomiting etc. depending on the location of the polyp.


Screening is the most important driver for the polyp market. Polyp are the most important risk factors for colon cancer and most colorectal cancers begin as a polyp, a growth in the tissue that lines the inner surface of the colon or rectum. A certain type of polyp known as an adenoma may have a higher risk of becoming a cancer and colorectal cancer is the third most common type of non-skin cancer in both men and women and is the second leading cause of cancer death in the United States after lung cancer. The U.S. Department of Health and Human Services estimates that in 2016, an estimated 134,490 people in the United States were diagnosed with colorectal cancer and 49,190 people died from contracting it.


The market drivers for polyp market are increasing geriatric population, growing screening, rising awareness and their potentially cancerous nature. The market restraints are risks such as bleeding and infection during surgery, low healthcare expenditure in developing regions, costs considerations especially for minimally invasive surgeries, no symptoms of most polyps, personal or family history of polyps etc.


Research Methodology:


 Research methodology Polyps Market


Sources: Mayo Clinic, Healthline Media, U.S. Department of Health and Human Services MRFR Analysis


Intended Audience



  • Global Polyps treatment manufacturers & suppliers

  • Research and development (R&D) companies

  • Hospitals and clinics

  • Academic institutes and universities


Global Polyps Market by Stage, 2016 (% market share)


 Polyps Market by Stage, 2016


Segments:


The polyps market has been segmented on the basis of stage, types, diagnosis, surgery and end users.


Based on stage, the market has been segmented as benign and pre-malignant.


Based on types, the market has been segmented as digestive polyps, endometrial polyp, cervical polyp, nasal polyps, laryngeal polyps and pre-malignant.


Based on diagnosis, the market has been segmented as occult blood and stool test, colonoscopy, sigmoidoscopy, double contrast barium enema, computed tomography and others.


Based on treatment, the market has been segmented as drugs which is further sub segmented into hormonal drugs, pain killers and others and surgery which is further sub segmented into polypectomy, minimally invasive surgery, colon and rectum removal and others.


Based on the end users, the market has been segmented as hospitals & clinics, academic and research and others.


Regional analysis:


The Americas account for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the fastest uptake of new technology in the US drives the polyps market. Also, concentration of major research companies and cancer research sector in the developed countries of this region is adding fuel to the market growth.


Europe is the second largest market in the world due to high income and healthcare penetration.


Asia Pacific region is expected to grow rapidly and China and India are likely to lead this market due to fast growing healthcare sector during the forecast period.


Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development.


Key Players in the Polyps Market


Some of key players profiled in the Polyps Market report are Millennium Surgical Corp., Black Smith Surgical, B. Braun Melsungen AG, Medtronic, Cook Medical, Endo Pharmaceuticals Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan Inc., Sun Pharmaceuticals and others. The report for Global Polyps market by Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain a deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes past and estimated future market size with respect to value and volume, technological advancement, macro economical and governing factors in the market. The report provides detail information about and strategies used by top key players in the industry. The Polyps Market report also gives a broad study of the different market segments and regions.

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.